BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 281 filers reported holding BLUEBIRD BIO INC in Q2 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $48,000 | -61.9% | 1,047 | -27.0% | 0.01% | -61.5% |
| Q4 2019 | $126,000 | -88.0% | 1,434 | -87.4% | 0.01% | -91.8% |
| Q3 2019 | $1,048,000 | +38.3% | 11,412 | +91.5% | 0.16% | -11.7% |
| Q2 2019 | $758,000 | -16.7% | 5,960 | +3.0% | 0.18% | -17.4% |
| Q1 2019 | $910,000 | +54.8% | 5,784 | -2.5% | 0.22% | +37.1% |
| Q4 2018 | $588,000 | -24.0% | 5,931 | +11.9% | 0.16% | -34.3% |
| Q3 2018 | $774,000 | -65.0% | 5,301 | -62.4% | 0.24% | -37.5% |
| Q2 2018 | $2,212,000 | +75.3% | 14,096 | +90.7% | 0.39% | +71.2% |
| Q1 2018 | $1,262,000 | – | 7,390 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Monashee Investment Management LLC | 125,000 | $13,131,000 | 5.55% |
| Cormorant Asset Management, LP | 275,000 | $28,889,000 | 4.79% |
| Eventide Asset Management | 569,700 | $59,847,000 | 3.73% |
| Crosspoint Capital Strategies, LLC | 28,937 | $3,040,000 | 2.66% |
| Casdin Capital, LLC | 65,000 | $6,828,000 | 2.53% |
| ARK Investment Management | 119,683 | $12,573,000 | 2.45% |
| RTW INVESTMENTS, LP | 104,383 | $10,965,000 | 2.31% |
| Taylor Wealth Management Partners | 38,368 | $4,031,000 | 1.82% |
| First Light Asset Management, LLC | 33,780 | $3,549,000 | 1.19% |
| Atika Capital Management LLC | 25,000 | $2,627,000 | 0.92% |